This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

How China's Probe of GlaxoSmithKline Could Play Out

TAIPEI, Taiwan (TheStreet) -- Chinese police are investigating GlaxoSmithKline (GSK) and making arrests related to allegations that employees paid bribes to sell drugs.

The Chinese Ministry of Public Security's probe over the past month also involves possible tax-related violations and has widened to include common employees of the British pharmaceutical giant as well as in-country management, official media say.

Eighteen people were arrested last week, China's official media reported.

I won't offer an opinion on what the company did or didn't do.

But if the courts say laws were broken, what happens to GlaxoSmithKline will probably follow one of three formulas for foreign multinationals facing legal problems in China.

Scenario 1. GSK has enough experience in China to know it should cooperate with investigators and keep a low public profile. Violations of the sort suspected in the current probe are considered standard operating procedures for Chinese companies. But if a foreign firm gets charged, despite any history of living closer to the law than its local peers, the charges stick at least in the media because China's ubiquitous nationalism favors local firms over foreign rivals.

Consider Foxconn (2317.TW), a Taiwanese consumer electronics assembler. A rash of suicides in 2010 and a mass worker strike hurt its public image and raised questions about labor conditions. One answer seeker was Apple (AAPL), which had hired Foxconn to make consumer electronics in China.

Analysts said at the time mainland Chinese firms were treating workers worse than Foxconn, but none faced the same scrutiny.

In November last year, labor rights activists accused Samsung Electronics of hiring girls as young as 16 at two China plants and requiring workers to sign blank contracts. The allegations grabbed attention because Samsung is a global brand. What about its local counterparts?

GSK, one of the world's biggest pharmaceutical makers, shows signs of working with Chinese authorities. If that cooperation goes well, the company might need to pay a fine and develop a well-publicized internal cure for whatever legal ailments that that the police find. Its executives have condemned whatever happened but not explained the acts in much detail.

Stock quotes in this article: GSK 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs